Navigation Links
Once affected by breast cancer it can strike back!

Once treated for breast cancer should not be a stimulation to be relieved as survivors have to be more cautious of secondary infection//.

This arises due to its treatment and or shared genetic predisposition or environmental risks compared with the general population.

According to the study the most likely cancers are stomach cancer, ovarian cancer, colorectal cancer, lung cancer, renal cancer, thyroid cancer, soft tissue sarcoma, endometrial cancer, melanoma, non-melanoma skin cancer, and leukemia. The lowest elevated risk is 22 percent for colorectal cancer and the highest elevated risk is 125 percent for soft tissue sarcoma.

The researchers were Dr. Lene Mellemkjaer and colleagues from the Danish Cancer Society in Copenhagen. The sample they took comprised 525,527 women from 13 population-based cancer registries who were diagnosed with breast cancer and followed for other malignancies during the period of 1943 to 2000.

The outcome of the study was that longer the survival period, the more likely the survivor gets a secondary cancer. The younger the age at which breast cancer was diagnosed, the more likely a secondary cancer will develop.
'"/>




Page: 1

Related medicine news :

1. Offsprings birth weight affected by fathers diabetes
2. Kidney function can be affected by lead exposure
3. Lumbar bone mineral density affected by daily physical activity
4. IVF results may be affected by stress and other related factors
5. Joint replacement surgery outcomes may be affected by obesity and diabetes
6. Doctors decisions are affected by fear of lawsuits- says a study
7. Wound healing affected by Psychological stress
8. Sick Swedish seagull was drunk, not affected by bird flu
9. Orissa found to be worst affected by the killer disease, AIDS
10. Tooth Decay Bacteria Unaffected By Altered Biochemical Pathway
11. Health conditions and patient treatment affected by a financial crunch

Post Your Comments:
(Date:12/1/2009)..., RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire...n 2001 and have expanded over the years serving th...facility which was originally set up in an area of...rvices, as part of the suite of services by Max Ne... as a valuable offering. ,, The pharmacy invent...
(Date:12/1/2009)...EHIGH VALLEY, Pa., Dec. 1 /PRNewswire-FirstCall/ -...mpleted the previously announced sale of the asset...ted under the Airthane® and Versathane® ...ary of global polyurethane chemicals producer COIM..., manufacturing facility in Paulsboro, N.J. Terms ...
(Date:12/1/2009)...WASHINGTON, Dec. 1 Indi...e more likely than those with traditional coverage...to be more engaged in wellness programs, and to be...matter in holding down costs, according to survey ... Benefit Research Institute (EBRI). ,, At the ...
(Date:12/1/2009)..., PHOENIX, Dec. 1 Abrazo Media Rel... Scoliosis ( http:// www.pedsorthopaedics.com ) lo...rthopaedic surgeon Dr. J. Hunt Udall to its practi... and orthopaedic surgery after recently completing...Boston, Massachusetts where he focused on adult an...
(Date:12/1/2009)... FORT LAUDERDALE, Fla., Dec. 1 Orb...enrollment in the randomized clinical trial of the...bo Stent). ,, A prospective, randomized, multic...n of an ablu M inal sirolimus coat ED bio- E... up to 20 sites in Asia, Australia, Europe and Sou...
Breaking Medicine News(10 mins):Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4
... was said that 44 % of women suffer from Intimate ...affects both the mental health as well as the phys...d by senior investigators of the Group Health Cent...erienced IPV during their adult lifetime. He ...
...st is to be conducted among children in the age gr...r the kids are following proper eating habits// an... health. This step is mainly to tackle the worseni...uld stigmatize some children. But the Government o...
...ingh asked the striking medicos to end strike and ...cable way and the students// should have faith in ...ion in the on-going protest against reservation fo...report to him. One of the plans is to increa...
...untants, lawyers joined the protesting medical stu...ace march started// at Maulana Azad Medical Colleg... surprisingly peaceful rally with no sloganeering....ing silently to let it be known that we feel stron...
...ined by other professionals including Bollywood st...the quota// increase for OBCs in higher educationa...torshri Hall in south Mumbai and march towards Aza...e held into the baton-charge on the medical studen...
...ere has claimed to have invented a device which ca...he muscles of his forehead.// The 'Galbenato...rd position in the engineering category at the rec... a point on the skin just above eyebrows as a data...
Other Medicine News:Health News:Prime Minister Asks Medicos to End Strike 2
(Date:12/1/2009)...-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYS...y completed preclinical study has affirmed the bio... Taxotere® (docetaxel). Shin Poong Pharmaceu...rea, independently conducted the study and data an...he bioequivalence and comparable overall safety of...
(Date:12/1/2009)...ewswire/ -- Sagent Pharmaceuticals, Inc., a privat...nnounced the launch of two antibiotics: cefoxitin ...USP. Both are antibiotics of the cephalosporin fam...am-negative bacteria. Sagent will launch ceftriaxo...ur vial sizes launched by Sagent in July 2008. Ce...
(Date:12/1/2009)...ewswire/ -- ,, Overweight Children May Develop... from The Children,s Hospital at Montefiore in New...may be causing damage to their spines. Researchers...ts between the ages of 12 and 20 who complained of...four-year period. The results showed an associatio...
Breaking Medicine Technology:ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Earliest animals lived in a lake environment research shows 9384 1Earliest animals lived in a lake environment research shows 9384 2Earliest animals lived in a lake environment research shows 9384 31 nano step closer to weighing a single atom 13222 11 nano step closer to weighing a single atom 13222 2Charging ahead 3A University of Houston team revealing secrets of electricity producing materials 13220 1Charging ahead 3A University of Houston team revealing secrets of electricity producing materials 13220 2Charging ahead 3A University of Houston team revealing secrets of electricity producing materials 13220 3
...profile and potential for lower cardiac toxicity d...t, SEATTLE, March 6 Cell Therapeutics, Inc.,(CTI...investigational drug,pixantrone will be studied in...ondation Charcot Stichting, in Brussels, Belgium, ... studying new therapies for the treatment,for mult...
... March 5 Transgenomic, Inc. (OTC,Bulletin Board: ...today,announced that it has entered into agreement...e Phase II trials representing more than $500,000 ...and our growing pharmaceutical partnerships and,pr...dation of our unique,mutation discovery and detect...
Other Medicine Technology:Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 2Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 3Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 4Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies 2
Genesis II Patellar Instruments
NexGen Complete Knee Solution IM Instrumentation
MIS Tibial Saw Guide
MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
Medicine Products: